Related Experiment Video
Updated: Sep 16, 2025
04:50
Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
Published on: January 17, 2025
412
Perihilar cholangiocarcinoma: a surgeon's perspective
1Department of Gastroenterological Surgery, Aichi Cancer Center, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan.
ILIVER
|July 10, 2025
Summary
Perihilar cholangiocarcinoma (PHC) management involves preoperative biliary drainage, often endoscopic, and surgical resection. Advances improve outcomes, but lymph node metastasis survival remains poor, necessitating adjuvant chemotherapy research.
Area of Science:
- Hepatobiliary Surgery
- Gastroenterology
- Surgical Oncology
Background:
- Perihilar cholangiocarcinoma (PHC) definition and staging have been revised.
- Obstructive jaundice is a common presentation, requiring preoperative biliary drainage.
Purpose of the Study:
- To review current management strategies for perihilar cholangiocarcinoma.
- To highlight challenges and future directions in PHC treatment.
Main Methods:
- Review of diagnostic and surgical techniques for PHC.
- Discussion of preoperative interventions like biliary drainage and portal vein embolization.
- Analysis of surgical outcomes and survival rates.
Main Results:
- Surgical outcomes and survival rates for PHC have improved due to advances in techniques.
- Endoscopic nasobiliary drainage is preferred for preoperative biliary drainage.
- Portal vein embolization is effective in minimizing postoperative liver dysfunction.
Conclusions:
- Surgical resection remains challenging but offers improved outcomes.
- Adjuvant chemotherapy protocols are urgently needed, especially for patients with lymph node metastasis.
- Multidisciplinary collaboration is crucial for advancing PHC treatment.
